
|Articles|June 18, 2007
Latebreakers: Revision made of Actos label
A request from the FDA has led to a revision of the prescribing information for pioglitazone (Actos, Takeda Pharmaceuticals).
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Retatrutide Delivers Weight Loss, A1C Improvements in Additional Trials
2
FDA Approves First-in-Class Centanafadine for Treatment of ADHD
3
Vaccine Serotypes Reemerge in Community-Acquired Pneumonia
4
New Study Shows Mail-Order Satisfaction Rising as Retail Trust Slips
5
























